282547-70-0

Upstream product

• 90-52-8 6-methoxyquinolin-8-amine 
• 55-51-6 N,N-bis(2-chloro-ethyl)-benzenemethanamine 

Downstream Products

• 282547-38-0 6-methoxy-8-piperazinoquinoline 
• 282547-60-8 8-(4-benzyl-piperazin-1-yl)-6-methoxy-1,2,3,4-tetrahydroquinoline 

Relevant academic research and scientific papers

Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor

The present invention relates to novel piperazine-piperidine compounds. The compounds are useful as 5-HT1A binding agents, particularly as 5-HT1A receptor antagonists and agonists. These compounds are useful in treating central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction.